ECT rekindles pharmacological response in schizophrenia

European Psychiatry

Volumn 24, Issue 8, 2009, Pages 521-525

  Hustig, H ^a   Onilov, R ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

ECT; Pharmacological responsiveness; Schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; PIMOZIDE; RISPERIDONE; SULPIRIDE; THIORIDAZINE; TRIFLUOPERAZINE; ZUCLOPENTHIXOL DECANOATE;

ADULT; ARTICLE; AUTOMUTILATION; CHRONICITY; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; FEMALE; GENERAL CONDITION DETERIORATION; GENERAL CONDITION IMPROVEMENT; HUMAN; MAINTENANCE THERAPY; MALE; OBSERVATIONAL STUDY; PATIENT SAFETY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RELAPSE; SCHIZOPHRENIA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; COMBINED MODALITY THERAPY; ELECTROCONVULSIVE THERAPY; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; SCHIZOPHRENIA; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 70449391353     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2009.04.005     Document Type: Article

References (17)

1. Arato M., and Bagdy G. Neuroendocrine study of the mechanisms of action of electroconvulsive therapy. Neuropsychobiology 8 (1982) 162-168
2. Brenner H.D., Dencker S.J., Goldstein M.J., et al. Defining treatment refractoriness in schizophrenia". Schizophr Bull 16 (1990) 551-561
3. Green A., Zalma A., Berman I., et al. Clozapine following ECT: two-step treatment. J Clin Psychiatry 55 (1994) 388-390
4. Green A.R., and Deakin J.W.F. Deletion of brain noradrenaline prevents electroconvulsive shock induced enhancement of 5-hydroxytryptamine and dopamine mediated behaviour. Nature 285 (1980) 232-233
5. Hirose, Shigehiro, Ashby Charles Jr R, Mills, Mark JJD. Effectiveness of ECT Combined with Risperidone Against Aggression in Schizophrenia. J ECT 2001;17:22-6.
6. James D.V., and Gray N.S. Elective combined electroconvulsive and clozapine therapy. Int Clin Psychopharmacol 14 (1999) 69-72
7. Janson L., Hellsten J., and Tingström A. Region Specific Hypothalamic Neuronal Activation and Endothelial Cell Proliferation in Response to Electroconvulsive Seizures. Biol Psychiatry 60 (2006) 874-881
8. Kho K.H., Blansjaar B.A., de Vries S., et al. Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia. Eur Arch Psychiatry Clin Neurosci 254 (2004) 372-379
9. Konig P., and Glatter-Gotz U. Combined electroconvulsive and neuroleptic therapy in schizophrenia refractory to neuroleptics. Schizophr Res 3 (1990) 351-354
10. Kupchik M., Spivak B., Mester R., et al. Combined electroconvulsive-clozapine therapy. Clin Neuropharmacol 23 (2000) 14-16
11. Modigh K. Long term effects of electroconvulsive shock therapy on synthesis, turnover and uptake of brain monoamines. Psychopharmacology 49 (1976) 179-185
12. Oprea N, Nacu A, Revenco M. Psihiatrie. Chisinau, Editura Stiinta; 1994.
13. Petrides G, Mendelowitz A. Preliminary findings in ECT augmentation of clozapine in clozapine-resistant psychotic patients. Personal communication, September 2000.
14. Predescu V. Psihiatria, vol.1, Editura Medicalǎ, Bucureşti; 1984.
15. Smith S.E., Acton L., and Sharp T. Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock. Psychopharmacology (2004) 85-94
16. Snejnevski G. Îndrumar în Psihiatrie. Moscova, Medicina; 1985.
17. Tang, Wai Kwong, Ungvari, Gabor S. Efficacy of Electroconvulsive therapy combined with antipsychotic medication in treatment-resistant schizophrenia: A prospective, open trial. J ECT 2002;18:90-4.